Literature DB >> 26031974

MTHFR 677C/T and 1298A/C mutations and non-alcoholic fatty liver disease.

Benan Kasapoglu1, Cansel Turkay2, Kadir Serkan Yalcin3, Ali Kosar4, Alper Bozkurt5.   

Abstract

Common genetic mutations encountered in folate metabolism may result in increased homocysteine (Hcy) levels. It has been reported that increased serum Hcy levels may affect the intracellular fat metabolism and may cause enhanced fatty infiltration in the liver resulting in non-alcoholic fatty liver disease (NAFLD). In total, 150 patients diagnosed with FLD by ultrasound examination and 136 healthy control patients that do not have any fatty infiltration in the liver were included in the study. Patients were grouped as mild (n = 88), moderate (n = 38) or severe (n = 24) according to the stage of fatty liver in ultrasound. Serum liver function tests, Hcy, folic acid and vitamin B12 levels of the patients were studied. The genetic MTHFR C677T and A1298C polymorphisms of the patients were also evaluated. Although there was no significant difference in vitamin B12 and folic acid levels, in the severe group, Hcy levels were significantly higher than that of control and mild groups (p<0.001). By contrast, there was no significant difference in heterozygote MTHFR 677C/T and 1298A/C mutations, both MTHFR 677C/T and MTHFR 1298A/C mutations were more common in NAFLD groups compared with the control patients (p<0.001). We have determined increased Hcy levels and increased prevalence of homozygote MTHFR 677C/T and MTHFR 1298A/C mutations in patients with NAFLD compared with healthy controls. Larger studies are warranted to clarify the etiological role of the MTHFR mutations and Hcy levels in FLD. © Royal College of Physicians 2015. All rights reserved.

Entities:  

Keywords:  MTHFR mutations; fatty liver disease; homocysteine

Mesh:

Substances:

Year:  2015        PMID: 26031974      PMCID: PMC4953108          DOI: 10.7861/clinmedicine.15-3-248

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  3 in total

1.  Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.

Authors:  Man-Yi Sun; Li Zhang; Song-Li Shi; Jing-Na Lin
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

2.  MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR).

Authors:  Xianchao An; Zonglin Yang; Zhengzhuang An
Journal:  Med Sci Monit       Date:  2017-05-16

3.  Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice.

Authors:  Lawrence Mabasa; Anri Kotze; Samukelisiwe Shabalala; Clare Kimani; Kwazi Gabuza; Rabia Johnson; Nonhlakanipho F Sangweni; Vinesh Maharaj; Christo J F Muller
Journal:  Int J Environ Res Public Health       Date:  2022-03-22       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.